Literature DB >> 2208794

Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections.

G Vanham1, L Kestens, P Gigase, R Colebunders, M Vandenbruaene, L Brijs, J L Ceuppens.   

Abstract

The activity of both cytotoxic T lymphocyte (CTL) and natural killer (NK) cells were measured cross-sectionally in 43 subjects seropositive for HIV, in 27 HIV- blood donors and in 24 HIV- persons from the Outpatients Clinic for sexually transmitted diseases. CTL activity was evaluated using the HL-60 cells coated with OKT3 as the targets and freshly separated peripheral blood lymphocytes as the effectors. In 20 out of 43 HIV+ subjects, CTL activity was significantly enhanced in comparison to the HIV- subjects. This lytic activity correlated positively with the percentages of CD3+ HLA-DR+, of CD8+ CR3- and of CD57+ CD16- lymphocytes, and was greatly reduced after elimination of CD8+, of HLA-DR+ or of CD57+ cells. The median CTL activity seemed to increase from CDC group II to CDC group IV (Centers for Disease Control classification), but to return back to control levels in those patients with a history of opportunistic infections. NK function in HIV+ subjects was not significantly different from that in the blood donors. In seropositive patients, NK activity correlated positively with the percentages of both CD16+ CD57+ and of CD8+ CR3+ cells and was strongly diminished after elimination of CD16+ or of CD57+ cells. There was no significant change in NK function according to the clinical stage. The data show that circulating CD8+ HLA-DR+ CD57+ T cells in HIV+ subjects are activated cytotoxic T cells and point to progressive (over) activation of this T cell compartment until the onset of opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208794      PMCID: PMC1535171          DOI: 10.1111/j.1365-2249.1990.tb05395.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Sideways killing: the cytolysis of Fc receptor-bearing cells through bridging to cytolytic T lymphocytes by antibodies specific for the T-cell receptor-T3 complex.

Authors:  M Ito; O Usuba; J C Unkeless; R Schreiber; F Celada; C A Bona; T M Moran
Journal:  Scand J Immunol       Date:  1989-06       Impact factor: 3.487

2.  Enhanced peripheral blood T-cell cytotoxicity in inflammatory bowel disease.

Authors:  F Shanahan; B Leman; R Deem; A Niederlehner; M Brogan; S Targan
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

3.  Lymphocyte subset analysis to predict progression to AIDS in a cohort of homosexual men in San Francisco.

Authors:  D P Stites; A R Moss; P Bacchetti; D Osmond; T M McHugh; Y J Wang; S Hebert; B Colfer
Journal:  Clin Immunol Immunopathol       Date:  1989-07

Review 4.  Virus-triggered AIDS: a T-cell-mediated immunopathology?

Authors:  R M Zinkernagel
Journal:  Immunol Today       Date:  1988-12

5.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Authors:  D F Nixon; A R Townsend; J G Elvin; C R Rizza; J Gallwey; A J McMichael
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

6.  Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.

Authors:  A Hoffenbach; P Langlade-Demoyen; G Dadaglio; E Vilmer; F Michel; C Mayaud; B Autran; F Plata
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

7.  Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes.

Authors:  P Langlade-Demoyen; F Michel; A Hoffenbach; E Vilmer; G Dadaglio; F Garicia-Pons; C Mayaud; B Autran; S Wain-Hobson; F Plata
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

8.  Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens.

Authors:  D H Shepp; F Daguillard; D Mann; G V Quinnan
Journal:  AIDS       Date:  1988-04       Impact factor: 4.177

9.  T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection.

Authors:  J E Morgan; C B Daul; R D de Shazo; W A Andes; N H Hyslop
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

Review 10.  Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases.

Authors:  B G Brenner; A Dascal; R G Margolese; M A Wainberg
Journal:  J Leukoc Biol       Date:  1989-07       Impact factor: 4.962

View more
  10 in total

1.  Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.

Authors:  L A Trimble; P Shankar; M Patterson; J P Daily; J Lieberman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  The effects of depression, stressful life events, social support, and coping on the progression of HIV infection.

Authors:  J Leserman
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

3.  Cytotoxic activity against maedi-visna virus-infected macrophages.

Authors:  W C Lee; I McConnell; B A Blacklaws
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.

Authors:  M D Grant; F M Smaill; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

5.  Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection.

Authors:  G Vanham; L Kestens; G Penne; C Goilav; P Gigase; R Colebunders; M Vandenbruaene; J Goeman; G van der Groen; J L Ceuppens
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

6.  Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue.

Authors:  P Dal Cin; M S Aly; J Delabie; J L Ceuppens; S Van Gool; B Van Damme; L Baert; H Van Poppel; H Van den Berghe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

7.  Association between serum-soluble CD8 levels and parameters of immune activation in patients with human immunodeficiency virus infection.

Authors:  G P Tilz; R Zangerle; G Weiss; P Fritsch; H Wachter; D Fuchs
Journal:  Clin Investig       Date:  1992-08

8.  Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis.

Authors:  M Schlesier; T Kaspar; J Gutfleisch; G Wolff-Vorbeck; H H Peter
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

Authors:  J H Vingerhoets; G L Vanham; L L Kestens; G G Penne; R L Colebunders; M J Vandenbruaene; J Goeman; P L Gigase; M De Boer; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

10.  Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies.

Authors:  S J Bowman; M Bhavnani; G C Geddes; V Corrigall; A W Boylston; G S Panayi; J S Lanchbury
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.